Hikma Pharmaceuticals Plc Director/PDMR Shareholding (7884S)
March 21 2016 - 10:54AM
UK Regulatory
TIDMHIK
RNS Number : 7884S
Hikma Pharmaceuticals Plc
21 March 2016
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters.
State whether the notification
relates to (i) a
transaction notified in
accordance with DTR 3.1.2
R,
(ii) a disclosure made in
accordance
LR 9.8.6R(1) or
(iii) a disclosure made
in accordance with section
793 of the Companies Act
Name of the issuer (2006).
1. HIKMA PHARMACEUTICALS PLC 2. (i) & (iii)
---- ----------------------------------- ---- --------------------------------------------------
3. Name of person discharging 4. State whether notification
managerial relates to a person
responsibilities/director connected with a person
discharging managerial responsibilities/director
ROBERT PICKERING named in 3 and identify
the connected person
N/A
---- ----------------------------------- ---- --------------------------------------------------
Indicate whether the notification
is in respect of a holding
of the person referred to Description of shares (including
in 3 or 4 above or in respect class), debentures or derivatives
of a nonbeneficial or financial instruments
interest 1 relating to shares
5. 3 ABOVE 6. ORDINARY SHARES OF 10P EACH
---- ----------------------------------- ---- --------------------------------------------------
Name of registered shareholders(s)
and, if more than one, the State the nature of the
number of shares held by transaction
each of them
MARKET PURCHASE OF 2,500
7. CHASE NOMINEES LIMITED 8. ORDINARY SHARES
---- ----------------------------------- ---- --------------------------------------------------
Percentage of issued class
Number of shares, debentures acquired (treasury shares
or financial of that class should not
instruments relating to be taken into account when
shares acquired calculating percentage)
9. 2,500 10. 0.001%
---- ----------------------------------- ---- --------------------------------------------------
Percentage of issued class
Number of shares, debentures disposed (treasury shares
or financial of that class should not
instruments relating to be taken into account when
shares disposed calculating percentage)
11. N/A 12. N/A
---- ----------------------------------- ---- --------------------------------------------------
Price per share or value
of transaction Date and place of transaction
13. GBP18.56p 14. 21 March 2016, London
---- ----------------------------------- ---- --------------------------------------------------
Total holding following
notification and total percentage
holding following notification
(any treasury shares should Date issuer informed of
not be taken into account transaction
when calculating percentage)
15. 10,000 (0.004%) 16. 21 March 2016
---- ----------------------------------- ---- --------------------------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer
complete the following boxes
Date of grant Period during which
or date on which exercisable
17. N/A 18. N/A
---- --------------------------- ---- ------------------------------
Total amount paid Description of shares
(if any) for grant or debentures involved
of the option (class and number)
19. N/A 20. N/A
---- --------------------------- ---- ------------------------------
Exercise price (if
fixed at time of grant) Total number of shares
or or debentures over
indication that price which options held
is to be fixed at following notification
the time of exercise
21. N/A 22. N/A
---- --------------------------- ---- ------------------------------
Name of contact and
telephone number for
Any additional information queries
PETER SPEIRS 0207
23. N/A 24. 399 2772
---- --------------------------- ---- ------------------------------
Name of authorised official of issuer responsible
for making notification
Peter Speirs, Company Secretary
Date of notification 21 March 2016
--------------------------------------------------
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) An issuer making a notification in respect
of a transaction relating to the shares
or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect
of a derivative relating the shares of
the issuer should complete boxes 1 to
4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect
of options granted to a director/person
discharging managerial responsibilities
should complete boxes 1 to 3 and 17 to
24.
(4) An issuer making a notification in respect
of a financial instrument relating to
the shares of the issuer (other than a
debenture) should complete boxes 1 to
4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBSGDXDUDBGLB
(END) Dow Jones Newswires
March 21, 2016 10:54 ET (14:54 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
